Literature DB >> 23244103

Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.

Jing Cui1, Liang Shen, Yu Wang.   

Abstract

BACKGROUND: The Cyclin D1(CCND1) G870A polymorphism may be associated with breast cancer, but the evidence from individual studies is inconclusive. The aim of this study was to investigate the correlation between the CCND1 G870A polymorphism and breast cancer risk in a meta-analysis.
MATERIALS AND METHODS: We searched Pubmed and analysed 11 articles on 5,528 cases and 5,353 controls before February 1, 2012.
RESULTS: we found there are significant association for AA versus GG and AA versus GA/GG. No significant associations were found for GA versus GG, GA/AA versus GG. There are significant association for AA versus GG ,and AA versus GA/GG in Caucasians. We didn't find any significant main effects for G870A polymorphism on breast cancer risk either in recessive or dominant models in Asians.
CONCLUSION: This meta-analysis suggests that AA of the CCND1 G870A polymorphism is associated with breast cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23244103     DOI: 10.7314/apjcp.2012.13.10.5023

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Association of CCND1 Gene c.870G>A Polymorphism with Breast Cancer Risk: A Case-ControlStudy and a Meta-Analysis.

Authors:  Zahra Soleimani; Davood Kheirkhah; Mohammad Reza Sharif; Alireza Sharif; Mohammad Karimian; Younes Aftabi
Journal:  Pathol Oncol Res       Date:  2016-12-21       Impact factor: 3.201

2.  The CCND1 G870A polymorphism and susceptibility to bladder cancer.

Authors:  Jing Li; Fei Luo; Hongtuan Zhang; Liang Li; Yong Xu
Journal:  Tumour Biol       Date:  2013-07-28

3.  Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis.

Authors:  Lili Wang; Zhiying Wang; Xiuqiu Gao; Xin Li; Xirao Sun; Changfu Liu
Journal:  Tumour Biol       Date:  2013-11-05

4.  Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.

Authors:  Zhenzhen Zeng; Jing Tu; Jin Cheng; Mingjie Yao; Yali Wu; Xiangbo Huang; Xiaomeng Xie; Xiaolei Zhang; Fengmin Lu; Xiangmei Chen
Journal:  Tumour Biol       Date:  2015-04-08

5.  CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma.

Authors:  Szymon Hryhorowicz; Katarzyna Ziemnicka; Marta Kaczmarek-Ryś; Justyna Hoppe-Gołębiewska; Andrzej Pławski; Marzena Skrzypczak-Zielińska; Małgorzata Szkudlarek; Monika Gołąb; Bartłomiej Budny; Marek Ruchała; Ryszard Słomski
Journal:  Oncol Lett       Date:  2014-10-15       Impact factor: 2.967

6.  Genetic association between cyclin D1 polymorphism and breast cancer susceptibility.

Authors:  XiaoRui Li; XiaoQing Huo; WeiWei Li; QingHui Yang; Ying Wang; XiaoChun Kang
Journal:  Tumour Biol       Date:  2014-11-17

7.  Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis.

Authors:  Xichao Dai; Xizhi Zhang; Buhai Wang; Chaomin Wang; Jingting Jiang; Changping Wu
Journal:  Med Sci Monit       Date:  2016-03-16

8.  Association between Cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trial sequential analysis.

Authors:  Nisha Thakur; Suchitra Kumari; Ravi Mehrotra
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.